Skip to main content
  • Main menu
  • User menu
  • Search
  • English ▼
    • English
    • Afrikaans
    • Albanian
    • Amharic
    • Arabic
    • Armenian
    • Azerbaijani
    • Basque
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Catalan
    • Cebuano
    • Chichewa
    • Chinese (Simplified)
    • Chinese (Traditional)
    • Corsican
    • Croatian
    • Czech
    • Danish
    • Dutch
    • Esperanto
    • Estonian
    • Filipino
    • Finnish
    • French
    • Frisian
    • Galician
    • Georgian
    • German
    • Greek
    • Gujarati
    • Haitian Creole
    • Hausa
    • Hawaiian
    • Hebrew
    • Hindi
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Indonesian
    • Irish
    • Italian
    • Japanese
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Korean
    • Kurdish (Kurmanji)
    • Kyrgyz
    • Lao
    • Latin
    • Latvian
    • Lithuanian
    • Luxembourgish
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Myanmar (Burmese)
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Polish
    • Portuguese
    • Punjabi
    • Romanian
    • Russian
    • Samoan
    • Scottish Gaelic
    • Serbian
    • Sesotho
    • Shona
    • Sindhi
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Spanish
    • Sudanese
    • Swahili
    • Swedish
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Turkish
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

English ▼
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scottish Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sudanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
OtherRADIATION SAFETY

133Xe Contamination Found in Internal Bacteria Filter of Xenon Ventilation System

Michael T. Hackett, Judith A. Collins and Rebecca S. Wierzbinski
Journal of Nuclear Medicine Technology September 2003, 31 (3) 170-172;
Michael T. Hackett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith A. Collins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca S. Wierzbinski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Abstract

Objective:

We report on 133Xe contamination found in the reusable internal bacteria filter of our xenon ventilation system.

Methods:

Internal bacteria filters (n = 6) were evaluated after approximately 1 mo of normal use. The ventilation system was evacuated twice to eliminate 133Xe in the system before removal of the filter. Upon removal, the filter was monitored using a survey meter with an energy-compensated probe and was imaged on a scintillation camera. The filter was monitored and imaged over several days and was stored in a fume hood.

Results:

Estimated 133Xe activity in each filter immediately after removal ranged from 132 to 2,035 kBq (3.6–55.0 μCi), based on imaging. Initial surface radiation levels ranged from 0.4 to 4.5 μSv/h (0.04–0.45 mrem/h). The 133Xe activity did not readily leave the filter over time (i.e., time to reach half the counts of the initial decay-corrected image ranged from <6 to >72 h). The majority of the image counts (~70%) were seen in 2 distinctive areas in the filter. They corresponded to sites where the manufacturer used polyurethane adhesive to attach the fiberglass filter medium to the filter housing.

Conclusion:

133Xe contamination within the reusable internal bacteria filter of our ventilation system was easily detected by a survey meter and imaging. Although initial activities and surface radiation levels were low, radiation safety practices would dictate that a 133Xe-contaminated bacteria filter be stored preferably in a fume hood until it cannot be distinguished from background before autoclaving or disposal.

  • 133Xe
  • radioactive contamination
  • radiation monitoring

As a part of routine monthly maintenance on our xenon ventilation system, we replace its internal bacteria filter (model 1549; A-M Systems, Inc.), which is reused after steam autoclaving. After removal of a bacteria filter that was going to be discarded (i.e., according to the manufacturer’s instructions, the filter can be autoclaved up to 25 times but should be discarded after 1 y of use), monitoring with a survey meter detected radioactivity. We report on 133Xe contamination found in the reusable internal bacteria filter of our xenon ventilation system.

MATERIALS AND METHODS

Each internal bacteria filter (n = 6) (Fig. 1) was evaluated after approximately 1 mo of normal use. The xenon ventilation system (Ventil-Con 3; RADX) was evacuated twice to eliminate 133Xe in the system before removal of the bacteria filter. Upon removal, the filter was immediately placed in a resealable plastic bag and monitored using a survey meter equipped with an energy-compensated probe. The maximum surface radiation level was recorded. The filter was then imaged for 5 min using a scintillation camera equipped with a low-energy all-purpose collimator and 20% energy window centered around 81 keV. The bacteria filter was removed from its resealable plastic bag and stored in a fume hood for several days. It was periodically monitored and imaged during that time. A used 133Xe vial was assayed in a dose calibrator and imaged on the scintillation camera to estimate the 133Xe activity in the bacteria filter. Background images were obtained for all sets of images.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Bacteria filter (arrow) (15 cm from filter inlet to filter outlet, 9-cm maximum diameter) inside xenon ventilation system. CO2 absorber is located in canister directly below filter. Filter and CO2 absorber are in constant contact with 133Xe in ventilation system. Moisture absorber is located in canister directly across from CO2 absorber canister. Moisture absorber comes into brief contact with 133Xe only when system is evacuated or during washout phase of ventilation study. During that time, 133Xe is trapped in internal shielded xenon filter (i.e., activated charcoal).

Based on imaging, the polyurethane adhesive used by the manufacturer to attach the fiberglass filter medium to the filter housing was thought to be the primary cause of the 133Xe retention. To confirm this suspicion, a small sample (∼4 × 5 × 15 mm) of the adhesive from a filter was placed in a sealed vial with 133Xe for several days. Upon removal from the vial, the adhesive sample was imaged over several days.

We also evaluated if 133Xe activity was found in the CO2 and moisture absorbers (i.e., soda lime granules and silica gel, respectively, n = 2 for both) on their removal from the ventilation system. After the bacteria filter was changed, each absorber was removed and placed in separate resealable plastic bags. The bags were monitored using a survey meter, and then, like the filter, they were imaged on a scintillation camera. The absorbers were stored in the fume hood with the plastic bag opened for approximately 7 h if 133Xe activity was detected. At that time, they were monitored and imaged.

RESULTS

Estimated 133Xe activity in each bacteria filter immediately after removal ranged from 132 to 2,035 kBq (3.6–55.0 μCi), based on imaging. The higher the estimated 133Xe concentration (MBq/L) of the ventilation system was before evacuation, the higher was the initial filter activity. Initial maximum surface-radiation levels ranged from 0.4 to 4.5 μSv/h (0.04–0.45 mrem/h), which correlated well with the estimated activity (Fig. 2). Background levels were 0.1 μSv/h (0.01 mrem/h). The 133Xe activity did readily leave the filter over time (i.e., time to reach half the counts of the initial decay-corrected image ranged from <6 to >72 h) (Fig. 3).

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Linear regression analysis between maximum surface-radiation level and estimated 133Xe activity in each bacteria filter immediately after removal from xenon ventilation system.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Percentage of activity remaining in bacteria filter based on initial decay-corrected scintillation camera counts versus time after filter removal.

The majority of the image counts (∼70%) were seen in 2 distinctive areas in the bacteria filter (Fig. 4). They corresponded to sites where the manufacturer used polyurethane adhesive to attach the fiberglass filter medium to the polypropylene filter housing (Fig. 5). To confirm that the adhesive was the primary cause of the 133Xe retention, a sample of the adhesive from a filter was placed in a sealed vial with 133Xe for several days. Imaging of the adhesive on removal from the vial demonstrated that the adhesive retained 133Xe activity, which was released slowly over time, as had been the case with the internal bacteria filters.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Images of typical bacteria filter after removal from xenon ventilation system. Top left is immediately after removal. Top right is 0.3 d after removal, with 75% of 133Xe activity remaining based on decay correction. Respective left and right bottom images are 3 and 7 d after removal, with 39% and 24% of 133Xe activity remaining based on decay correction. Two hottest bands of activity correspond to 2 polyurethane adhesive areas in filter.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Cross-section of bacteria filter. Polyurethane adhesive area (open arrow) toward filter inlet is circular, with 6-cm diameter and 3- to 5-mm thickness. Other polyurethane adhesive area (solid arrows), toward filter outlet, is doughnut shaped with 4-cm inner diameter, 7.5-cm outer diameter, and 4- to 5-mm thickness. Fiberglass filter medium is between and attached to 2 adhesive areas so as to secure it to polypropylene filter housing.

One bacteria filter had increased initial 133Xe activity throughout. The increase was probably due to incomplete evacuation of the 133Xe activity from the xenon ventilation system before removal. This would explain its quicker release of 133Xe activity (○ line in Fig. 3) when compared with the other filters.

The moisture absorber showed no detectable 133Xe activity on removal, whereas the CO2 absorber did. The 2 CO2 absorbers had estimated 133Xe activities of 157.7 and 308.8 kBq (4.3 and 8.3 μCi), with low maximum surface-radiation levels of 0.3 and 0.4 μSv/h (0.03 and 0.04 mrem/h), respectively. No detectable 133Xe activity in the CO2 absorber could be found after storage in the fume hood for 7 h.

DISCUSSION

Normally, we think of radioxenon contamination as resulting from a xenon spill (e.g., vial breaks or patient removes mask during ventilation study). We have shown that 133Xe contamination is present in the reusable internal bacteria filter and CO2 absorber of our ventilation system. One would not expect to see this type of contamination—of an inert radioactive gas—in a bacteria filter or CO2 absorber. Because the filter is internal, there is a constant presence of 133Xe in the filter (and the CO2 absorber) if the ventilation system has activity loaded (i.e., does not include activity in the xenon trap), thus allowing time for the 133Xe to adsorb to the plastic contents of the bacteria filter (i.e., primarily to the polyurethane adhesive) and to the CO2 absorber. Radioxenon adsorption to plastic syringes (1,2) and to rubber and plastic stoppers and components (1–5) has been reported. Radioxenon contamination of polystyrene packing materials from 133Xe shipments (5–7), plastic packaging jackets that house shielded 133Xe vials (6), and polyurethane packing materials (8) and activated carbon absorbent packets (9) from 131I capsule shipments (i.e., 131mXe contamination) has been reported.

CONCLUSION

133Xe contamination within the reusable internal bacteria filter and CO2 absorber of our ventilation system was easily detected by survey meters and imaging. Although initial activities and surface radiation levels were low, radiation safety practices would dictate that a 133Xe-contaminated bacteria filter and CO2 absorber be stored preferably in a fume hood until it cannot be distinguished from background before autoclaving or disposal.

Acknowledgments

This study was presented at the 48th annual meeting of the Society of Nuclear Medicine in Toronto, Ontario, Canada, in June 2001.

Footnotes

  • For correspondence contact: Michael T. Hackett, MS, CNMT, Radiation Safety Office/Nuclear Medicine Service (115-CDD), Department of Veterans Affairs Medical Center, 1101 Veterans Dr., Lexington, KY 40502-2236.

    E-mail: michael.hackett{at}med.va.gov

REFERENCES

  1. Keaney J, Liuzzi A, Freedman GS. Large dose errors due to redistribution of 133Xe in carpules and plastic syringes. J Nucl Med. 1971;12:249.–250.
  2. Ponto RA, Loken MK. Radioactive gases: production, properties, handling, and uses. In: Subramanian G, Rhodes BA, Cooper JF, Sodd VJ, eds. Radiopharmaceuticals. New York, NY: Society of Nuclear Medicine, Inc.; 1975:296–304.
  3. Kowalsky RJ, Dalton DR, Saylor WL. A simple device for efficient transfer and unit dose packaging of Xe-127: concise communication. J Nucl Med. 1978;19:414.–418.
  4. Kowalsky RJ. Stability of Xe-127 in unit dose vials. J Nucl Med Technol. 1979;7:222.–225.
  5. Hackett MT, Collins JA, Wierzbinski RS. Evaluation of 133Xe leakage from used and unused vials [abstract]. J Nucl Med Technol. 2001;29:118.
  6. Lieto RP, Morrison N. Radioxenon packaging contamination. J Nucl Med Technol. 1985;13:218.–221.
  7. Hackett MT, Magoun SL. Radioactive contamination of packing materials from a xenon-133 shipment. J Nucl Med Technol. 2000;28:56.–59.
  8. Verbruggen AM, DeRoo M. Contamination of the packing material of sodium iodide (131I) therapy capsules with an unexpected radionuclide. Eur J Nucl Med. 1983;8:406.–407.
  9. Hackett MT. Additional radiation safety concerns involving sodium iodide-131 capsules [reply to letter]. J Nucl Med Technol. 1996;24:139.–141.
SNMMI

© 2025 SNMMI

Powered by HighWire

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.